Latvija -
latviešu -
Zāļu valsts aģentūra
iohexol icg farma 755 mg/ml šķīdums injekcijām
uab icg farma, lithuania - joheksols - Šķīdums injekcijām - 755 mg/ml
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
inaqovi
otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leikēmija, mieloīds - antineoplastiski līdzekļi - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
orserdu
stemline therapeutics b.v. - elacestrant - krūts audzējs - endokrīnā terapija - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.